Moneycontrol
    Moneycontrol PRO

    Markets

    Jump to

    • Moneycontrol Pro Panorama | A tale of two export engines

      In this edition of Moneycontrol Pro Panorama: India may need to renegotiate tougher deal with US, continuous uncertainty weighs in on the rupee, rising US-Iran tensions risk dangerous regional escalation, bullion prices may surge amid global instability, and more

    • Eris Lifesciences partners with Natco Pharma to launch semaglutide in India

      The collaboration follows Natco’s recent approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture generic semaglutide, setting up a planned launch in March 2026.

    • Smaller IPOs slow down as market turns selective, valuations trimmed; foreign banks gain ground

      Indian IPO markets have cooled, with valuations down 25-30% from 2024 peaks as foreign and retail investors retreat.

    • Will bullion test new highs?

      After a sharp selloff shook out leveraged traders, the question on every bullion investor's mind is whether gold and silver are gearing up for fresh all-time highs

    • Biocon ramps up biosimilar push, eyes global semaglutide rollout as capex eases

      As Shreehas Tambe readies to take charge of the unified Biocon Group following the integration of Biocon Biologics, the company is entering what he calls a “capacity‑rich, demand‑heavy” phase—one where margins improve as capital and R&D intensity taper off.

    • Moneycontrol Pro Panorama | Tariff defanged

      In this edition of Moneycontrol Pro Panorama: US tariff ruling heightens global trade uncertainty, flash PMIs signal caution for investors, China-Pakistan ties exaggerated yet caution warranted, tariffs don't disappear they evolve, and more

    • CDSCO to get 1,500‑member scientific cadre, will speed up drug approvals

      The government has agreed ‘in principle’ to the move and a proposal would be send for approval by March, DGCI Rajeev Singh Raghuvanshi has said

    • Will “remove rot of cough‑syrup manufacturing” by next production season: Central drug controller

      The regulator has already inspected around 1,150 facilities, or 90% of cough syrup making plants, physically visiting plants and taking enforcement action wherever serious lapses were found.

    • Moneycontrol Pro Market Outlook | Tariff shock to keep markets on edge

      Last week Nifty closed at 25,571 with a 0.39% gain. Benchmarks rose despite volatility while small caps fell. The outlook is still bearish and selling pressure may continue

    • SC strikes down Trump tariffs but experts believe Street cheer likely to be short-lived

      Indian markets are set to open higher after the US Supreme Court struck down Donald Trump’s tariff order, but experts warned that continued uncertainty around future tariff rates may limit upside

    • Moneycontrol Pro Weekender | All that is solid melts into air

      AI power lies not just in its intelligence, but in its speed -- and that speed is disrupting everything

    • Everstone‑backed Integris Medtech gets SEBI nod for IPO

      The Everstone Capital–backed company, India’s second‑largest home‑grown diversified medtech platform by FY25 operating revenue, plans to raise up to Rs 925 crore through a fresh issue of shares, alongside an offer for sale of 21.67 million shares from existing investors and founders.

    • Moneycontrol Pro Panorama | Making AI count

      For Moneycontrol Pro Panorama Feb 20 edition: India’s AI potential depends on institutional reforms, regulator increases insurance rules, rooftop solar growth faces significant challenges, China and India diversify investments, and more

    • RBI’s MTF circular won’t change leverage, but it may change how retail investors use it

      The RBI circular tightens rules on how brokers borrow from banks by insisting on fully secured funding, higher haircuts on pledged equity collateral and stricter cash requirements.

    • Nobody knows very much about where alpha comes from

      Academic and computer-generated stock predictors show similar performance. Knowing the reason behind their success offers little advantage. Quantitative investors should focus on data-driven strategies rather than theoretical explanations

    • Regulator tightens the screws on insurance business – What should investors do?

      Insurance commissions could be next in the regulator’s sights for a clean-up act, posing a threat to non-life insurers, in particular  

    • Gaudium IVF IPO opens tomorrow: GMP signals decent listing; key things to know before you apply

      Gaudium IVF IPO GMP: The allotments are likely to be finalised by February 25, and the shares are scheduled to be listed on stock exchanges on February 27.

    • ONGC, Oil India shares jump up to 7% as rising US-Iran tensions push oil prices higher; HPCL, BPCL fall up to 4%

      Oil prices are rallying as investors remain concerned over the possibility of US action against Iran.

    • Moneycontrol Pro Panorama | Rural FMCG demand takes a tumble

      For Moneycontrol Pro Panorama Feb 19 edition: AI risks deepening inequality, growth visible in Q3 earnings yet stability uncertain, AI agents hiring humans raises concerns, and more

    • Bank Nifty falls 1%, breaches key support levels amid overall market downturn: Check key trading levels

      The Nifty Bank index has slipped below the 61,000 mark, snapping a three-session gaining streak.

    • Small, midcap stocks plunge up to 5% amid overall market weakness: Check top losers

      Given persistent global uncertainties and elevated market volatility, traders are advised to maintain discipline and be selective, focusing on fundamentally strong stocks during market corrections, an analyst said.

    • Sensex, Nifty tumble nearly 1.5%: Trump's possible action against Iran leaving markets jittery, say analysts

      In the short run, we can expect a range-bound market with high volatility, an analyst said.

    • Sensex falls 1,200 pts, Nifty down 1.4%: Will bear attack continue or can bulls make a comeback? Analysts suggest trading levels

      Nifty 50 has broken a key support level of 25,650 which was suggested by analysts.

    • Upcoming IPOs: Clean Max, PNGS Reva Diamond among 3 mainboard IPOs opening next week, check latest GMP

      IPO news: The maiden public issue of Gaudium IVF will spill over from this week, after opening tomorrow (February 20).

    • Infosys, TCS, Coforge other IT stocks rise up to 2% after Wall Street tech rally

      IT stocks: Today's rise comes after a massive tech selloff after Anthropic’s launch of new AI tools, leading to worries about an AI-led disruption in the sector.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347